Ginsenoside Rg3 has also been shown to increase the expression of tumor suppressor von Hippel-Lindau (VHL) gene in ovarian cancer cells via suppressing DNMT3A expression and thus downregulating the DNA methylation level of the VHL promoter (Wang et al., 2021). This evidence concerns the gene DNMT3A and ovarian carcinoma.